Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Beta-blocker Administration on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replacement B-TAVR

NCT06472934 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT06472934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06472934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Beta-blocker Administration on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replacement B-TAVR
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Not applicable
Overall status
Recruiting
Start date
July 4, 2024
Completion date
May 31, 2028
Enrollment
498 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis